Tags: tygacil | warning | fda | death | antibiotic | pneumonia

FDA Warns: Pfizer Antibiotic Raises Death Risk

Friday, 27 Sep 2013 03:22 PM

Regulators are putting their harshest warning on Pfizer's antibiotic Tygacil, saying the drug is associated with an increased risk of death.

The Food and Drug Administration says Tygacil should only be used in situations when other treatments aren't suitable. The drug is approved as a treatment for complicated skin and skin structure infections and community-acquired bacterial pneumonia. The FDA will add a boxed warning to the drug label, its most serious type of warning.

In 2010 the FDA said Tygacil was associated with a greater risk of death than other antibacterial drugs. It says a new analysis confirmed that conclusion. The risk was greatest in patients with ventilator-associated pneumonia. Tygacil hasn't been approved for that condition.

The New York drugmaker reported $335 million in Tygacil revenue last year.

© Copyright 2015 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

1Like our page
2Share
Health-News
Regulators are putting their harshest warning on Pfizer's antibiotic Tygacil, saying the drug is associated with an increased risk of death. The Food and Drug Administration says Tygacil should only be used in situations when other treatments aren't suitable. The drug is...
tygacil,warning,fda,death,antibiotic,pneumonia
128
2013-22-27
 

The information presented on this website is not intended as specific medical advice and is not a substitute for professional medical treatment or diagnosis. Read Newsmax Terms and Conditions of Service.

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved